3645-45-2

Basic information

• Product Name: 1,2-Benzenedicarboxylic acid dihydrazide
• Synonyms: 1,2-Benzenedicarboxylic acid dihydrazide
• CAS NO: 3645-45-2
• Molecular Formula: C₈H₁₀N₄O₂
• Molecular Weight: 194.1906
• Mol File: 3645-45-2.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1,2-Benzenedicarboxylic acid dihydrazide(CAS DataBase Reference)
• NIST Chemistry Reference: 1,2-Benzenedicarboxylic acid dihydrazide(3645-45-2)
• EPA Substance Registry System: 1,2-Benzenedicarboxylic acid dihydrazide(3645-45-2)

Safety Data

• Hazardous Substances Data: 3645-45-2(Hazardous Substances Data)

Usage

Uses

Used in Plastics Industry:
1,2-Benzenedicarboxylic acid dihydrazide is used as a monomer in the production of polyimides, which are high-performance plastics known for their exceptional thermal and chemical resistance. Its incorporation into polyimide synthesis contributes to the creation of materials with superior mechanical and thermal stability, making them suitable for applications in harsh environments.
Used as a Curing Agent in Epoxy Resins:
In the coatings and adhesives industry, 1,2-Benzenedicarboxylic acid dihydrazide serves as a curing agent for epoxy resins. Its use enhances the cross-linking process, leading to improved mechanical properties and thermal stability of the final product. This makes it an essential component in the formulation of high-performance coatings and adhesives.
Used as a Cross-Linking Agent for Polymers:
1,2-Benzenedicarboxylic acid dihydrazide is utilized as a cross-linking agent in the polymer industry. Its ability to form covalent bonds between polymer chains results in materials with enhanced mechanical strength and thermal stability. This makes it a valuable additive in the production of various polymer-based products, including films, fibers, and composites.
Used in Manufacturing of Adhesives, Coatings, and Laminates:
Due to its ability to improve the mechanical and thermal properties of materials, 1,2-Benzenedicarboxylic acid dihydrazide is employed in the manufacturing of adhesives, coatings, and laminates. Its incorporation into these products results in enhanced performance characteristics, such as increased adhesion, durability, and resistance to temperature fluctuations.
Potential Applications in Pharmaceutical Industry:
1,2-Benzenedicarboxylic acid dihydrazide has potential applications in the pharmaceutical industry, where it may be used as an intermediate in the synthesis of various drug compounds. Its unique chemical structure and reactivity make it a promising candidate for the development of new therapeutic agents.
Used as a Corrosion Inhibitor in Industrial Processes:
In various industrial processes, 1,2-Benzenedicarboxylic acid dihydrazide can be employed as a corrosion inhibitor. Its ability to form stable complexes with metal surfaces helps protect them from corrosion, extending the service life of equipment and reducing maintenance costs. This makes it a valuable additive in applications such as oil and gas pipelines, chemical processing equipment, and other industries where corrosion resistance is crucial.

Upstream product

• 84-66-2 Diethyl phthalate 
• 64-17-5 ethanol 
• 7803-57-8 hydrazine hydrate 
• 5460-29-7 2-(3-bromopropyl)isoindole-1,3-dione 
• 473437-99-9 2-(8-oxo-8H-indeno[1,2-c]thiophen-1-yl)isoindoline-1,3-dione 
• 281197-48-6 Np-(4-fluorobenzyl)-Na-phthaloyihistamine 
• 191544-76-0 Np-(4-cyanobenzyl)-Na-phthaloylhistamine 
• 81099-39-0 Acetic acid 2-[2-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-ethylsulfanyl]-2-(5-iodo-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-ethyl ester 
• 52096-60-3 2-<2-(Methylthio)ethyl>-1H-isoindole-1,3(2H)-dione 
• 81068-55-5 2-{2-[2-Hydroxy-1-(5-iodo-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-ethylsulfanyl]-ethyl}-isoindole-1,3-dione 
• 81068-54-4 2-{2-[1-(5-Fluoro-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-2-hydroxy-ethylsulfanyl]-ethyl}-isoindole-1,3-dione 
• 81068-66-8 2-[2-(5-Iodo-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-2-methylsulfanyl-ethyl]-isoindole-1,3-dione 
• 81068-67-9 2-[2-(5-Fluoro-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-2-methylsulfanyl-ethyl]-isoindole-1,3-dione 
• 108-24-7 acetic anhydride 

Downstream Products

• 15100-70-6 Benzol-1,2-dicarbonsaeure-bis-dichloracetylhydrazid 
• 112008-80-7 disalicylaldehyde phthaloyldihydrazone 
• 1384973-99-2 13-(4-hydroxyphenyl)-3, 3-dimethyl-3,4-dihydro-1H-indazolo[1,2-b]phthalazine-1,6,11(2H, 13H)-trione 
• 1017238-96-8 13-(4-fluorophenyl)-3,3-dimethyl-2,3,4,6,11,13-hexahydro-1H-indazolo[1,2-b]phthalazine-1,6,11-trione 
• 1204395-07-2 3,4-dihydro-3,3-dimethyl-13-(4-methoxyphenyl)-2Hindazolo[2,1-b]phthalazine-1,6,11(13H)-trione 
• 1017238-97-9 3,3-dimethyl-13-(4-nitrophenyl)-3,4-dihydro-2H-indazolo[1,2-b]phthalazine-1,6,11(13H)-trione 
• 1415214-11-7 3,3-dimethyl-13-(2-nitrophenyl)-2,3,4,6,11,13-hexahydro-1H-indazolo[1,2-b]phthalazine-1,6,11-trione 
• 1017238-93-5 3,4-dihydro-3,3-dimethyl-13-phenyl-2H-indazolo[1,2-b]phthalazine-1,6,11(13H)-trione 
• 1017238-94-6 3,3-dimethyl-13-(4-chlorophenyl)-3,4-dihydro-2H-indazolo[1,2-b]phthalazine-1,6,11(13H)-trione 
• 1017238-95-7 3,4-dihydro-3,3-dimethyl-13-(4-bromophenyl)-2H-indazolo[2,1-b]phthalazine-1,6,11(13H)-trione 
• 1017239-00-7 3,3-dimethyl-13-(4-methylphenyl)-3,4-dihydro-1H-indazolo[1,2-b]phthalazine-1,6,11(2H,13H)-trione 
• 1173891-44-5 13-(2,4-dichlorophenyl)-3,3-dimethyl-3,4-dihydro-1H-indazolo[1,2-b]phthalazine-1,6,11(2H,13H)-trione 
• 1017238-98-0 13-(2-chlorophenyl)-3,3-dimethyl-3,4-dihydro-2H-indazolo[1,2-b]phthalazine-1,6,11(13H)-trione 
• 1278520-01-6 13-(2,3-dichlorophenyl)-3,3-dimethyl-3,4-dihydro-1H-indazolo[1,2-b]phthalazine-1,6,11(2H,13H)-trione 

Relevant articles and documents

NOVEL INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE

Novel compounds and pharmaceutical compositions are disclosed which are inhibitors of the enzyme, farnesyl-protein transferase. Also disclosed is a method of inhibiting Ras function and therefore inhibiting the abnormal growth of cells. The method comprises administering the novel aminooxyamide compound to a biological system. In particular, the method inhibits the abnormal growth of cells in a mammal such as a human.

Low molecular weight inhibitors of complement proteases

Peptide substances, their preparation and their use as complement inhibitors are described. These are in particular substances having a guanidine or amidine radical as a terminal group. In particular, inhibitors of the complement proteases C1s and C1r are

Pharmaceutically active compounds and methods of use

New fused thiophene compounds are provided and methods of using those compounds for a variety of therapeutic indications. Compounds of the invention are particularly useful for treatment of neuropathic pain.

N - ( 2 - aryl - propionyl ) - sulfonamides and pharmaceutical preparations containing them

The compounds of formula 1, wherein R and R2 are as defined in the disclosure, are useful in the prevention and treatment of tissue damage due to exacerbated recruitment of polymorphonuclear neutrophils (PMN leukocytes) at the inflammatory sites.

CHELATING COMPOUNDS, THEIR COMPLEXES WITH PARAMAGNETIC METALS

Compounds able to chelate bi- and trivalent paramagnetic metal ions, their chelated complexes with said metal ions and the physiologically compatible salts thereof, as well as the use thereof as contrast agents in the technique known as “Magnetic Resonanc

Functionalized ferrocenyldiphosphines, a process for their preparation and their use

The invention relates to 1,2-ferrocenyldiphosphines which contain a functional group in the 1′ position either directly or via a bridging group, and also a process for their preparation. The compounds are important for transition metal complexes containing d-8 metals such as Rh, Ru, Pd or Ir. These transition metal complexes are widely used in the hydrogenation of organic double or triple bonds, in particular olefinic double bonds and carbon-heteroatom double bonds. The complexes are particularly suitable for enantioselective hydrogenation using chiral ferrocenyldiphosphines and corresponding prochiral unsaturated compounds. Ferrocenyldiphosphines having a functional group in the 1′ position are also important intermediates for ferrocenyldiphosphine ligands and their metal complexes of d-8 metals such as rhodium, ruthenium, palladium or iridium which are bound to inorganic polymeric supports via this functional group. These metal complexes bound to an inorganic or organic support material are likewise very suitable for the hydrogenation of organic double or triple bonds.

Process and intermediates for preparing 4'-trifluoromethylbiphenyl-2-carboxylic acid [2-(2H-[1,2,4]triazol-3-ylmethyl)-1,2,3,4-tetrahydro-isoquinolin-6-yl]-a mide

A process for preparing the compound of formula (1) is disclosed. STR1 The starting materials are an N-triazolylmethyl-6-aminoisoquinoline and a 4-biphenyl-2-carboxylic acid derivative.

DNA-affinic hypoxia selective cytotoxins

Hypoxia selective cytotoxins having the structural formula STR1 wherein D, E, F and G, independently, are carbon or nitrogen, with the proviso that three or more of D, E, F and G are carbon; R1 and R2, independently, are selected fro

Acridine-intercalator based hypoxia selective cytotoxins

Hypoxia selective cytotoxins of the general formula STR1 wherein n is from 1 to 5, and NO2 is in at least one of the 2, 4 or 5-positions of the imidazole. Such compounds have utility as radiosensitizers and chemosensitizers.

Synthesis and Characterization of Nitrato and Acetato Complexes of Dioxouranium(VI) with Disalicylaldehyde Acyl Hydrazones

Dioxouranium(VI) complexes of disalicylaldehyde oxaloyldihydrazone (H4A2), malonoyldihydrazone (H4B2), succinoyldihydrazone (H4C2), glutaroyldihydrazone (H4D2), adipoyldihydrazone (H4E2) and phthaloyldihydrazone (H4F2) have been synthesized from the reaction of uranyl nitrate hexahydrate and uranyl acetate dihydrate with the title ligands in alcoholic medium.The complexes have the compositions .2H2O and .C2H5OH where H4L2 = H4A2, H4B2, H4C2, H4D2, H4E2 and H4F2.The complexes have been characterized on the basis of elemental analyses, TGA, DTA, molar conductance, infrared and Raman spectral data.